Baird Financial Group Inc. Decreases Stock Position in GE HealthCare Technologies Inc. $GEHC

Baird Financial Group Inc. reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 141,640 shares of the company’s stock after selling 41,586 shares during the period. Baird Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $10,491,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Trust Advisors LP boosted its stake in GE HealthCare Technologies by 69.1% during the 2nd quarter. First Trust Advisors LP now owns 829,321 shares of the company’s stock valued at $61,428,000 after acquiring an additional 338,942 shares during the last quarter. Guggenheim Capital LLC boosted its holdings in GE HealthCare Technologies by 22.3% in the second quarter. Guggenheim Capital LLC now owns 131,985 shares of the company’s stock worth $9,776,000 after purchasing an additional 24,087 shares during the period. CW Advisors LLC increased its stake in GE HealthCare Technologies by 5.6% during the second quarter. CW Advisors LLC now owns 10,297 shares of the company’s stock valued at $763,000 after purchasing an additional 547 shares during the last quarter. Locust Wood Capital Advisers LLC raised its holdings in shares of GE HealthCare Technologies by 11.6% during the second quarter. Locust Wood Capital Advisers LLC now owns 1,946,345 shares of the company’s stock worth $144,166,000 after purchasing an additional 202,027 shares during the period. Finally, Beacon Pointe Advisors LLC lifted its position in shares of GE HealthCare Technologies by 4.3% in the 2nd quarter. Beacon Pointe Advisors LLC now owns 11,479 shares of the company’s stock worth $850,000 after buying an additional 472 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 3.6%

GE HealthCare Technologies stock opened at $85.46 on Monday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market capitalization of $38.93 billion, a PE ratio of 17.66, a price-to-earnings-growth ratio of 3.57 and a beta of 1.09. The firm has a 50 day simple moving average of $75.95 and a 200-day simple moving average of $74.52.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on GEHC shares. BTIG Research reaffirmed a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their target price for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 1st. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Finally, Evercore ISI upped their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $86.45.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.